Legal & General Group
BSX icon

Legal & General Group’s Boston Scientific BSX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.07B Sell
9,993,286
-874,798
-8% -$94M 0.27% 64
2025
Q1
$1.1B Buy
10,868,084
+129,278
+1% +$13M 0.3% 56
2024
Q4
$959M Sell
10,738,806
-399,753
-4% -$35.7M 0.25% 64
2024
Q3
$933M Sell
11,138,559
-255,140
-2% -$21.4M 0.25% 70
2024
Q2
$877M Sell
11,393,699
-25,761
-0.2% -$1.98M 0.25% 72
2024
Q1
$782M Buy
11,419,460
+44,544
+0.4% +$3.05M 0.23% 85
2023
Q4
$658M Buy
11,374,916
+121,548
+1% +$7.03M 0.2% 102
2023
Q3
$594M Sell
11,253,368
-251,576
-2% -$13.3M 0.21% 97
2023
Q2
$622M Buy
11,504,944
+742,518
+7% +$40.2M 0.2% 100
2023
Q1
$538M Buy
10,762,426
+236,481
+2% +$11.8M 0.19% 110
2022
Q4
$487M Sell
10,525,945
-319,607
-3% -$14.8M 0.19% 122
2022
Q3
$420M Sell
10,845,552
-320,625
-3% -$12.4M 0.16% 127
2022
Q2
$416M Buy
11,166,177
+409,391
+4% +$15.3M 0.15% 146
2022
Q1
$476M Buy
10,756,786
+880,914
+9% +$39M 0.14% 141
2021
Q4
$420M Sell
9,875,872
-398,544
-4% -$16.9M 0.13% 172
2021
Q3
$446M Buy
10,274,416
+551,217
+6% +$23.9M 0.14% 146
2021
Q2
$416M Buy
9,723,199
+541,219
+6% +$23.1M 0.14% 155
2021
Q1
$355M Sell
9,181,980
-110,300
-1% -$4.26M 0.13% 166
2020
Q4
$334M Buy
9,292,280
+237,625
+3% +$8.54M 0.13% 167
2020
Q3
$346M Sell
9,054,655
-17,785
-0.2% -$680K 0.15% 144
2020
Q2
$319M Sell
9,072,440
-96,545
-1% -$3.39M 0.15% 144
2020
Q1
$300M Buy
9,168,985
+387,556
+4% +$12.7M 0.18% 132
2019
Q4
$397M Buy
8,781,429
+226,587
+3% +$10.2M 0.19% 118
2019
Q3
$348M Sell
8,554,842
-33,425
-0.4% -$1.36M 0.18% 124
2019
Q2
$369M Buy
8,588,267
+17,999
+0.2% +$774K 0.2% 107
2019
Q1
$329M Buy
8,570,268
+1,567,394
+22% +$60.2M 0.19% 116
2018
Q4
$247M Buy
7,002,874
+598,647
+9% +$21.2M 0.19% 114
2018
Q3
$247M Buy
6,404,227
+280,645
+5% +$10.8M 0.18% 130
2018
Q2
$200M Sell
6,123,582
-260,671
-4% -$8.52M 0.15% 153
2018
Q1
$174M Sell
6,384,253
-294,307
-4% -$8.04M 0.13% 182
2017
Q4
$166M Sell
6,678,560
-82,438
-1% -$2.04M 0.12% 203
2017
Q3
$197M Buy
6,760,998
+232,309
+4% +$6.78M 0.15% 169
2017
Q2
$181M Buy
6,528,689
+163,465
+3% +$4.53M 0.15% 173
2017
Q1
$158M Buy
6,365,224
+233,391
+4% +$5.8M 0.13% 182
2016
Q4
$133M Sell
6,131,833
-90,557
-1% -$1.96M 0.12% 194
2016
Q3
$148M Buy
6,222,390
+42,211
+0.7% +$1M 0.15% 162
2016
Q2
$144M Buy
6,180,179
+267,960
+5% +$6.26M 0.15% 159
2016
Q1
$111M Buy
5,912,219
+34,936
+0.6% +$657K 0.12% 190
2015
Q4
$108M Sell
5,877,283
-11,444
-0.2% -$211K 0.12% 196
2015
Q3
$96.6M Buy
5,888,727
+119,532
+2% +$1.96M 0.12% 201
2015
Q2
$102M Buy
5,769,195
+138,476
+2% +$2.45M 0.12% 199
2015
Q1
$100M Sell
5,630,719
-113,743
-2% -$2.02M 0.12% 207
2014
Q4
$76.1M Sell
5,744,462
-168,090
-3% -$2.23M 0.09% 261
2014
Q3
$69.8M Sell
5,912,552
-201,167
-3% -$2.38M 0.08% 266
2014
Q2
$78.1M Buy
6,113,719
+44,973
+0.7% +$574K 0.09% 253
2014
Q1
$82M Sell
6,068,746
-209,752
-3% -$2.84M 0.1% 233
2013
Q4
$75.5M Sell
6,278,498
-72,964
-1% -$877K 0.09% 247
2013
Q3
$74.6M Sell
6,351,462
-319,606
-5% -$3.75M 0.1% 239
2013
Q2
$61.8M Buy
+6,671,068
New +$61.8M 0.09% 272